Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence.
Ontology highlight
ABSTRACT: Recent studies have reported that the gut microbiota influences mood and cognitive function through the gut-brain axis, which is involved in the pathophysiology of neurocognitive and mental disorders, including Parkinson's disease, Alzheimer's disease, and schizophrenia. These disorders have similar pathophysiology to that of cognitive dysfunction in bipolar disorder (BD), including neuroinflammation and dysregulation of various neurotransmitters (i.e., serotonin and dopamine). There is also emerging evidence of alterations in the gut microbial composition of patients with BD, suggesting that gut microbial dysbiosis contributes to disease progression and cognitive impairment in BD. Therefore, microbiota-centered treatment might be an effective adjuvant therapy for BD-related cognitive impa
SUBMITTER: Dai W
PROVIDER: S-EPMC9168430 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA